NYU Langone Health: Pancreatic Cancer Cells Secrete Signal That Sabotages Immune Attack on Tumors
January 09, 2020
January 09, 2020
NEW YORK, Jan. 9 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
Akey immune signal has a previously unknown role in turning off the immune system's attack on pancreatic cancer cells, a new study finds.
Led by researchers at NYU Grossman School of Medicine, the study found that an immune signaling protein, interleukin-1 (IL-1), is made and released by pancreatic tumor cells. This was shown to redu . . .
Akey immune signal has a previously unknown role in turning off the immune system's attack on pancreatic cancer cells, a new study finds.
Led by researchers at NYU Grossman School of Medicine, the study found that an immune signaling protein, interleukin-1 (IL-1), is made and released by pancreatic tumor cells. This was shown to redu . . .